P

Inventor

DEATON DAVID NORMAN

US12 patents
⚠️ This page may combine multiple inventors who share the name “DEATON DAVID NORMAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE BEECHAM CORP

4 patents
US6455507B1Sep 24, 2002

Benzimidazole derivatives

SMITHKLINE BEECHAM CORP27 citations88
US7282512B2Oct 16, 2007

Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors

SMITHKLINE BEECHAM CORP1 citations47
US7288541B2Oct 30, 2007

Propylcarbamate derivatives as inhibitors of serine and cysteine proteases

SMITHKLINE BEECHAM CORP0 citations43
US7402606B2Jul 22, 2008

Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss

SMITHKLINE BEECHAM CORP0 citations37

GLAXO WELLCOME INC

2 patents
US6294580B1Sep 25, 2001

Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma

GLAXO WELLCOME INC48 citations88
US6172064B1Jan 9, 2001

Formamides as therapeutic agents

GLAXO WELLCOME INC12 citations71

GLAXOSMITHKLINE LLC

2 patents
US7705028B2Apr 27, 2010

Farnesoid X receptor agonists

GLAXOSMITHKLINE LLC6 citations69
US7960552B2Jun 14, 2011

Farnesoid X receptor agonists

GLAXOSMITHKLINE LLC3 citations57

GLAXOSMITHKLINE IP DEV LTD

2 patents
US11053234B2Jul 6, 2021

1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors

GLAXOSMITHKLINE IP DEV LTD0 citations59
US11149035B2Oct 19, 2021

Chemical compounds as H—PGDS inhibitors

GLAXOSMITHKLINE IP DEV LTD0 citations45

CALDWELL RICHARD

1 patent
US8158665B2Apr 17, 2012

Farnesoid X receptor agonists

CALDWELL RICHARD12 citations79

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD

1 patent
US9840496B2Dec 12, 2017

CD38 inhibitors and methods of treatment

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD1 citations42